Remove 2000 Remove Clinical Trials Remove Decriminalization Remove Topical
article thumbnail

CBD is Everywhere – But Where Does the FDA Stand?

The Blunt Truth

The public hearing attracted over 100 speakers and 2000 participants. 331(ll)), the FDA prohibits the sale of products containing an ingredient that has been treated as a drug or involved in clinical trials, without prior FDA approval. Under section 331(ll) of the FD&C Act (21 U.S.C. First, Sens. 726) in March of 2019.

CBD 80
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Rick Doblin, Ph.D,